Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Initiation and Maintenance Disorders 4 Neoplasms 4 Anxiety Disorders 4 Fatigue 3 Depression 2 Breast Neoplasms 2 Weight Loss 1 Weight Gain 1 Tobacco Use Disorder 1 Substance-Related Disorders 1 Nervous System Diseases 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Melanoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Inflammation 1 Glioma 1 Generalized Anxiety Disorder 1 Cognitive Dysfunction 1 Chronic Pain 1 Burnout, Psychological 1

Interventions

Magnetic Resonance Spectroscopy 19 Temozolomide 16 Radiotherapy 10 Specimen Handling 7 Blood Specimen Collection 7 Radiation 6 Bevacizumab 5 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 vorasidenib 3 trametinib 3 pembrolizumab 3 olaparib 3 fludarabine 3 dabrafenib 3 Watchful Waiting 3 Surgical Procedures, Operative 3 Magnetic Resonance Imaging 3 Drug Therapy 3 olutasidenib 2 lutetium Lu 177 dotatate 2 fluorodopa F 18 2 fluciclovine F-18 2 entrectinib 2 contrast agent BR1 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Flucytosine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × Cognitive Behavioral Therapy × Clear all

NCT06468176 2025-12-19

FREEDOME

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Glioma, Neoplasms, Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡